QQ客服 官方微博 反馈留言

	AVE 3085, a novel endothelial nitric oxide synthase enhancer, attenuates cardiomyocyte hypertrophy through reducing oxidative stress (CPCI-S收录)
	Chen Yili[1,2]; Yao Fengjuan[3]; Huang Huiling[1,2]; Lin Chunxi[1,2]; He Jiangui[1,2]
会议名称	JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
URL标识	查看原文
内容类型	会议论文
URI标识	http://www.corc.org.cn/handle/1471x/2044468
专题	华南理工大学
作者单位	1.[1]Sun Yat Sen Univ, Dept Cardiol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China 2.[2]Key Lab Assisted Circulat, Guangzhou, Guangdong, Peoples R China 3.[3]Sun Yat Sen Univ, Affiliated Hosp 1, Dept Ultrasound, Guangzhou, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Chen Yili[1,2],Yao Fengjuan[3],Huang Huiling[1,2],等. AVE 3085, a novel endothelial nitric oxide synthase enhancer, attenuates cardiomyocyte hypertrophy through reducing oxidative stress (CPCI-S收录)[C]. 见:JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。